Estimating antibiotics consumption in a tertiary care hospital in Islamabad using a WHO's defined daily dose methodology.

Authors:
Jabeen N; Ullah W; Khalid J; Samad Z.

Journal:
Antimicrob Resist Infect Control

Publication Year: 2023

DOI:
10.1186/s13756-023-01311-2

PMCID:
PMC10666294

PMID:
37996947

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Antimicrob Resist Infect Control

Abbreviation: Antimicrob Resist Infect Control

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Automated surveillance of non-ventilator-associated hospital-acquired pneumonia (nvHAP): a systemat…
Wolfensberger A; Scherrer AU; Sax H. (2024) - Transparency Score: 4/6
Barriers, facilitators, perceptions and impact of interventions in implementing antimicrobial stewa…
Harun MGD; Sumon SA; Hasan I and 3 more (2024) - Transparency Score: 3/6
Clinically relevant sequence types of carbapenemase-producing Escherichia coli and Klebsiella pneum…
Heljanko V; Tyni O; Johansson V and 8 more (2024) - Transparency Score: 4/6
Emergence and clonal expansion of Aeromonas hydrophila ST1172 that simultaneously produces MOX-13 a…
Chen X; Lu M; Wang Y and 8 more (2024) - Transparency Score: 4/6
Hip prosthesis and colon surgery, a decade of surveillance on surgical site infections in Italy, a …
Bordino V; Vicentini C; Cornio AR and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethical approvalInitially, this research study’s ethical approval was obtained from the Institutional Review Board & Ethics Committee (IRB&EC), Shifa International Hospitals Ltd. (SIH) and Shifa Tameer-e-Millat University (STMU) Islamabad (Ref: IRB# 065 − 22). Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025